Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Journal of Neurosurgical Sciences|July 1, 1982
Pituitary hormone concentrations in cerebrospinal fluid in patients with prolactin and growth hormone-secreting tumorsE Rolandi, C Perria, V Cicchetti, et al.Cytokine|May 1, 1997
Biphasic control of NF-kappa B activation induced by the triggering of HLA-DR antigens expressed on B cellsA Leonardi, M Altomonte, M Maio, et al.Cancer Research|July 15, 1993
Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cellsM Altomonte, A Gloghini, G Bertola, et al.Thyroid : Official Journal of the American Thyroid Association|March 10, 1998
Intercellular adhesion molecule-1 is upregulated via the protein kinase C pathway in human thyroid carcinoma cell linesV Bassi, S De Riu, A Feliciello, et al.Melanoma Research|October 1, 1995
Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigenE Baharav, O Merimsky, M Altomonte, et al.American Journal of Clinical Oncology|December 1, 1996
Melanoma-associated hypopigmentation: where are the antibodies?O Merimsky, Y Shoenfeld, E Baharav, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR)S Coral, L Sigalotti, A Gasparollo, et al.British Journal of Cancer|January 1, 1997
Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cellsE Fonsatti, M Altomonte, S Coral, et al.International Journal of Cancer|March 17, 2001
Unbalanced expression of HLA-A and -B antigens: a specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-gammaA Gasparollo, S Coral, M Ciullo, et al.La Clinica Terapeutica|August 25, 2000
Emerging role of protectin (CD59) in humoral immunotherapy of solid malignanciesE Fonsatti, M Altomonte, S Coral, et al.Pageof 7